Innovations In Clinical Neuroscience

SEP-OCT 2014

A peer-reviewed, evidence-based journal for clinicians in the field of neuroscience

Issue link: http://innovationscns.epubxp.com/i/425963

Contents of this Issue

Navigation

Page 27 of 201

Innovations in CLINICAL NEUROSCIENCE [ V O L U M E 1 1 , N U M B E R 9 – 1 0 , S E P T E M B E R – O C T O B E R 2 0 1 4 ] 28 T ABLE 2. Negative and positive prospective reports of SIB during study participation based on study type and most severe lifetime suicidal ideation reported at baseline. BASELINE REPORTED LIFETIME SIB PSYCHIATRIC STUDY PARTICIPANTS NONPSYCHIATRIC STUDY PARTICIPANTS Prospective Behavior Prospective Behavior Negative Positive OR (95% CI)* Negative Positive OR (95% CI)* No suicidal ideation 3,150 34 -- 1,768 5 -- Passive ideation 1,282 69 4.99 (3.3–7.6) **** 139 1 2.54 (0.3–21.9) ns Active ideation, no method 536 32 5.53 (3.4–9.0) ** 67 0 -- Active ideation, method, no intent 665 60 8.36 (5.4–12.8) ** 47 3 22.57 (5.2–97.2) ** Active ideation, method, intent, no plan 468 77 15.24 (10.1–23.1)** 36 0 -- Active ideation, method, intent, and plan 322 65 18.70 (12.2–28.8) ** 9 2 78.58 (13.4–459.4)** BASELINE REPORTED LIFETIME SIB Prospective Ideation Prospective Ideation Negative Positive OR (95% CI)* Negative Positive OR (95% CI)* No suicidal ideation 3,181 3 -- 1,773 0 -- Passive ideation 1,333 18 14.32 (4.2–48.7)** 140 0 -- Active ideation, no method 556 12 22.89 (6.4–81.4)** 67 0 -- Active ideation, method, no intent 705 20 30.08 (8.9–101.5)** 50 0 -- Active ideation, method, intent, no plan 508 37 77.23 (23.7–251.4)** 36 0 -- Active ideation, method, intent, and plan 362 25 73.23 (22.0–243.7)** 11 0 -- * Patients reporting no lifetime suicidal ideation served as the reference group for computing odds ratio and confidence intervals. ns p>0.05 ** p<0.001 SIB: suicidal ideation and behavior

Articles in this issue

Archives of this issue

view archives of Innovations In Clinical Neuroscience - SEP-OCT 2014